RPLP2 and diffuse large B-cell lymphoma: Eight SEGs in MA-K, RPLP2, RPS16, MRPS16, SSPN, CD52, VPREB3, CCDC82, and ANKRD37, were identified as promising prognostic biomarkers of human DLBCL.